NCT02324335 2019-01-16BrilacidinInnovation Pharmaceuticals, Inc.Phase 2 Completed61 enrolled 12 charts
NCT00918281 2014-06-09Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) InjectionGE HealthcarePhase 2 Completed70 enrolled 9 charts